GlassScriptPhysician profile
Stephanie Glaser
NPI 1932762804
$4,926.24
in general payments reported to CMS, 2019-2025
26 companies · $711 in 2025
The $711 reported for 2025 was more than what 78% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $608 · 2022: $1,606 · 2023: $1,509 · 2024: $493 · 2025: $711.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,713.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,712.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $790.36 | 2021-2024 | Xarelto |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $646.14 | 2021-2025 | Lifevest |
| Novartis Pharmaceuticals Corporation | $585.67 | 2021-2025 | |
| Pfizer INC. | $575.21 | 2022-2025 | |
| E.R. Squibb & Sons, L.L.C. | $320.33 | 2022-2025 | Eliquis, Camzyos |
| Astrazeneca Pharmaceuticals LP | $279.95 | 2021-2024 | Farxiga |
| Boehringer Ingelheim Pharmaceuticals, INC. | $223.95 | 2022-2025 | Jardiance |
| Amgen INC. | $212.77 | 2021-2025 | Repatha, Repatha |
| Silk Road Medical, INC. | $154.21 | 2022-2023 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent |
| Merck Sharp & Dohme LLC | $120.17 | 2022-2024 | Verquvo |
| Bayer Healthcare Pharmaceuticals INC. | $119.53 | 2022-2023 | |
| Edwards Lifesciences Corporation | $113.31 | 2023 | Sapien 3 Ultra Resilia |
| Esperion Therapeutics, INC. | $112.91 | 2021-2023 | Nexletol |
| Actelion Pharmaceuticals US, INC. | $107.14 | 2022-2025 | Uptravi, Opsumit |
| Boston Scientific Corporation | $99.93 | 2024-2025 | Versacross Access Solution, General - Structural Heart, General - Balloon Catheters |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $92.09 | 2021-2023 | |
| Abbott Laboratories | $82.68 | 2023-2025 | Cardiomems, Diamondback Coronary, Jot Dx |
| Biosense Webster, INC. | $80.55 | 2024 | Carto 3 |
| Amarin Pharma, INC. | $67.27 | 2021-2022 | |
| Philips North America LLC | $24.71 | 2024 | (Ck4) Mcot |
| Atricure, INC. | $24.50 | 2023 | |
| Tactile Systems Technology INC | $23.86 | 2025 | Nimbl, Flexitouch Plus |
| Regeneron Healthcare Solutions, INC. | $21.12 | 2023 | Evkeeza, Praluent |
| Medtronic, INC. | $18.97 | 2021 | |
| Kestra Medical Technology Services, INC. | $15.30 | 2024 | Assure Wcd |
| Abiomed | $13.61 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephanie Glaser listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.